Skip to main content
Marshall Glesby, MD, Infectious Disease, New York, NY, New York-Presbyterian Hospital

MarshallJayGlesbyMDPhD

Infectious Disease New York, NY

HIV/AIDS Medicine

Professor of Medicine, Weill Cornell Medical College

Dr. Glesby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Glesby's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1992 - 1996
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1989 - 1992
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1997 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2013-2014
  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Moderate Alcohol Use Is Not Associated with Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Women: A Prospective Cohort Study  
    Phyllis C Tien, Marshall J Glesby, Michael Augenbraun, Marion G Peters, Clinical Infectious Diseases

Lectures

  • CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • HIV Patients Fare Well with Mpox Treatment
    HIV Patients Fare Well with Mpox TreatmentMay 5th, 2023
  • NIH Grant Funds Antibiotic Trial for Patients with HIV and Emphysema
    NIH Grant Funds Antibiotic Trial for Patients with HIV and EmphysemaDecember 13th, 2022
  • How a Select Few People Have Been Cured of HIV
    How a Select Few People Have Been Cured of HIVOctober 5th, 2022
  • Join now to see all

Grant Support

  • Complications Of Chronic Viral InfectionsNational Institute Of Allergy And Infectious Diseases2008–2011
  • A5229 Lipoatrophy StudyNational Center For Research Resources2007
  • Study Of Safety And Efficacy Of Rhgh A/O Rosiglitazone In HIVNational Center For Research Resources2006–2007
  • Growth Hormone And Rosiglitazone For Visceral AdoposityNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2007
  • Suppressive Long-Term Antiviral Management Of HCV And HIV Coinfected SubjectsNational Center For Research Resources2005–2007
  • Growth Hormone And Rosiglitazone For Hiv-Associated LipodystrophyNational Center For Research Resources2005
  • A5127: PH II Trial/ Adefovir Dipivoxil/ Tenofovir Disoproxil Fumarate/ HEP B/ HNational Center For Research Resources2005
  • A5163: Phase II, Study Of Alendronate In HIV W/ Decreased BMDNational Center For Research Resources2004–2005
  • Growth Hormone And Rosiglitazone For Visceral AdiposityNational Institute Of Diabetes And Digestive And Kidney Diseases2004
  • A5127: PH. II Trial/ Adefovir Dipivoxil/ Tenofovir Disoproxil Fumarate/ HEP B/ HNational Center For Research Resources2004

Hospital Affiliations